(brinzolamide, timolol)

eye drops (suspension) 10 mg/ml + 5 mg/ml

Pharmachological effect

Combined antiglaucoma preparation, contains two active ingredients: brinzolamide and timolol maleate. These two components decrease elevated IOP primarily by reducing aqueous humour secretion, but do so by different mechanisms of action. The combined effect of these two active substances results in additional IOP reduction compared to either compound alone.

Indications for use

Open-angle glaucoma, increased intraocular pressure, not amenable to monotherapy..

Release form

Per 5 ml polyethylene vial-droppers.